Lipocine Inc.
LPCN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $11,198 | -$2,851 | $500 | $16,141 |
| % Growth | 492.8% | -670.2% | -96.9% | – |
| Cost of Goods Sold | $0 | $10,175 | $8,557 | $7,666 |
| Gross Profit | $11,198 | -$13,026 | -$8,057 | $8,475 |
| % Margin | 100% | 456.9% | -1,611.4% | 52.5% |
| R&D Expenses | $7,352 | $0 | $0 | $0 |
| G&A Expenses | $5,001 | $4,905 | $4,062 | $5,330 |
| SG&A Expenses | $5,001 | $4,905 | $4,062 | $5,330 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $12,353 | $4,905 | $4,062 | $5,330 |
| Operating Income | -$1,155 | -$17,931 | -$12,119 | $3,146 |
| % Margin | -10.3% | 629% | -2,423.9% | 19.5% |
| Other Income/Exp. Net | $1,164 | $1,580 | $1,361 | -$3,780 |
| Pre-Tax Income | $9 | -$16,351 | -$10,758 | -$634 |
| Tax Expense | $1 | $1 | $1 | $0 |
| Net Income | $8 | -$16,352 | -$10,759 | -$634 |
| % Margin | 0.1% | 573.6% | -2,151.7% | -3.9% |
| EPS | 0.002 | -3.14 | -2.15 | -0.19 |
| % Growth | 100.1% | -46% | -1,031.6% | – |
| EPS Diluted | -0.002 | -3.14 | -2.05 | -0.12 |
| Weighted Avg Shares Out | 5,339 | 5,270 | 4,993 | 3,302 |
| Weighted Avg Shares Out Dil | 5,423 | 5,270 | 5,256 | 5,154 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,147 | $1,367 | $573 | $68 |
| Interest Expense | $0 | $0 | $27 | $203 |
| Depreciation & Amortization | $41 | $29 | $9 | $0 |
| EBITDA | -$1,114 | -$17,902 | -$10,721 | -$431 |
| % Margin | -9.9% | 628% | -2,144.3% | -2.7% |